Testing a Decision Aid for Women With Urogenital Prolapse
Primary Purpose
Pelvic Organ Prolapse
Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
decision aid developed for pelvic organ prolapse
Sponsored by
About this trial
This is an interventional health services research trial for Pelvic Organ Prolapse focused on measuring shared decision making
Eligibility Criteria
Inclusion Criteria:
- urogenital prolaps symptoms
- e boks
Exclusion Criteria:
- complicated pelvic organ prolapse which requires treatment other than dialogue, pessary, cystocele or rectocele surgery, physiotherapy or local hormones
- physical status classification system (ASA) score 3 or above
- not able to understand Danish without interpreter
- recurrent pelvic organ prolapse
Sites / Locations
- Hospital of Southern Jutland
- Hospital of Lillebaelt, Kolding
- Odense University Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
No Intervention
Arm Label
Intervention with use of decision aid in the consultation
Control with no use of decision aid in the consultation
Arm Description
With use of developed decision aid for pelvic organ prolapse / At the beginning of the consultation the IF will be opened within the patients electronic journal. The conversation will take its starting point from the generated IF which should define the area of interest rather for the patient.
Without decision aid / The conversation during the consultation will follow the general standard for consultation conversations in the department.
Outcomes
Primary Outcome Measures
PROM of the shared decision making process
Measurement of shared decision making for treatment of pelvic organ prolapse symptoms measured by questionnaire SDM-Q-9
Secondary Outcome Measures
PROM of Satisfaction with decision
Measurement of satisfaction with the decision for treatment of pelvic organ prolapse symptoms measured by questionnaire SWD
Full Information
NCT ID
NCT03706716
First Posted
October 11, 2018
Last Updated
April 30, 2019
Sponsor
University of Southern Denmark
1. Study Identification
Unique Protocol Identification Number
NCT03706716
Brief Title
Testing a Decision Aid for Women With Urogenital Prolapse
Official Title
Support Women's Decision Making - the Effect of Using an Online App in the Clinical Consultations of Patients With Urogenital Prolapse. A Protocol for a Randomized Controlled Non Blinded Multicenter Study. Assessing Feasibility.
Study Type
Interventional
2. Study Status
Record Verification Date
April 2019
Overall Recruitment Status
Completed
Study Start Date
June 7, 2018 (Actual)
Primary Completion Date
March 22, 2019 (Actual)
Study Completion Date
April 26, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Southern Denmark
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Development of a decision aid for women with urogenital prolapse followed by an intervention with use of the decision aid to investigate the effect on the perceived shared decision making in the clinical consultations.
A protocol for a randomized controlled non blinded multicenter trial. A feasibility trial for the protocol.
Detailed Description
Objective :
The objective is to develop a decision aid to increase successful patient involvement and increased health care professionals integration of preferences in the clinical consultations with women with urogenital prolapse.
Method:
in the context of consultations an online app solution using a multicriterial analytic approach is developed and tested in order to support shared decision making (SDM). The decision aid is developed involving four national gynecological departments through participatory design. The decision aid is tested in a randomized, controlled multicenter trial in three hospital departments in the Region of Southern Denmark. A feasibility trial for the protocol of a randomized controlled trial will decide for further approach in relations to testing the online app. in a larger scale In the randomized trial patients will either receive consultations as usual (controls) or consultations using the interface (IF) in an app. The IF is generated upon data from a patient survey regarding their preferences for treatment beforehand.
Effect measures are the perceived shared decision making within the consultation (SDM-Q-9 ) and the patientperceived satisfaction with the decision (SWD)
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pelvic Organ Prolapse
Keywords
shared decision making
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Arm A - intervention /consultation with use of decision aid Arm B - Controls / consultation without use of decision aid
Masking
None (Open Label)
Allocation
Randomized
Enrollment
82 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Intervention with use of decision aid in the consultation
Arm Type
Other
Arm Description
With use of developed decision aid for pelvic organ prolapse / At the beginning of the consultation the IF will be opened within the patients electronic journal. The conversation will take its starting point from the generated IF which should define the area of interest rather for the patient.
Arm Title
Control with no use of decision aid in the consultation
Arm Type
No Intervention
Arm Description
Without decision aid / The conversation during the consultation will follow the general standard for consultation conversations in the department.
Intervention Type
Other
Intervention Name(s)
decision aid developed for pelvic organ prolapse
Intervention Description
Conversation based upon the inter face in the Electronic patient journal.
Primary Outcome Measure Information:
Title
PROM of the shared decision making process
Description
Measurement of shared decision making for treatment of pelvic organ prolapse symptoms measured by questionnaire SDM-Q-9
Time Frame
1 hour immediately after the decision on treatment was taken
Secondary Outcome Measure Information:
Title
PROM of Satisfaction with decision
Description
Measurement of satisfaction with the decision for treatment of pelvic organ prolapse symptoms measured by questionnaire SWD
Time Frame
1 hour immediately after the decision on treatment was taken
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
urogenital prolaps symptoms
e boks
Exclusion Criteria:
complicated pelvic organ prolapse which requires treatment other than dialogue, pessary, cystocele or rectocele surgery, physiotherapy or local hormones
physical status classification system (ASA) score 3 or above
not able to understand Danish without interpreter
recurrent pelvic organ prolapse
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mette Hulbaek, Ph.d. stud.
Organizational Affiliation
Gynecology dep, Southern hospital of Jutland
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital of Southern Jutland
City
Aabenraa
ZIP/Postal Code
6200
Country
Denmark
Facility Name
Hospital of Lillebaelt, Kolding
City
Kolding
ZIP/Postal Code
6000
Country
Denmark
Facility Name
Odense University Hospital
City
Odense
ZIP/Postal Code
5000
Country
Denmark
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
34238835
Citation
Hulbaek M, Primdahl J, Birkelund R, Al-Kozai SAH, Barawi S, Ebbesen NT, Nielsen JB. A Preference-Sensitive Online Instrument to Support Shared Decision Making for Patients With Pelvic Organ Prolapse: A Pilot Multicenter Randomized Controlled Trial. Comput Inform Nurs. 2021 Jul 12;39(11):714-724. doi: 10.1097/CIN.0000000000000789.
Results Reference
derived
Learn more about this trial
Testing a Decision Aid for Women With Urogenital Prolapse
We'll reach out to this number within 24 hrs